Warner Bros. Discovery, Inc.
INHIBITING DEUBIQUITINASE USP25 AND USP28

Last updated:

Abstract:

The present disclosure relates to modulators, such as inhibitors, of at least one pathway chosen from USP28 and USP25, pharmaceutical compositions comprising the inhibitors, and methods of using the inhibitors. The modulators, such as inhibitors, of at least one pathway chosen from USP28 and USP25 can be useful in the treatment of cancers, among other ailments. The present disclosure provides compounds of Formula (I). ##STR00001##

Status:
Application
Type:

Utility

Filling date:

8 Aug 2019

Issue date:

17 Jun 2021